Current practice in AT for RTW: Factors influencing speech pathologist's AT prescription for people with CCD post TBI.
| Tuesday, May 28, 2024 |
| 3:10 PM - 3:25 PM |
| Knowledge Hub |
Overview
Presenter
Current practice in AT for RTW: Factors influencing speech pathologist's AT prescription for people with CCD post TBI.
3:10 PM - 3:25 PMPresentation summary
Our objective is to provide insight into the current practices and factors which may influence speech pathologists in the prescription and utilisation of these technologies to support RTW goals.
Our methods encompassed a mixed-methods approach, utilising a survey developed to capture the types of AT used and identify the barriers and facilitators of its use. Content analysis and reflexive thematic analysis was employed to analyse participant responses. Information available to speech pathologist to support the decision making around AT was further explored through a document analysis of speech pathology association practice documents related to AT prescription and TBI.
The results of our research reveal speech pathologists employ a range of AT including devices, applications, and websites to primarily support communication and memory difficulties. Thematic analysis resulted in a central organising concept of ‘a nuanced approach’ with five themes. Participants highlighted a number of barriers to AT prescription and use which related to AT ‘design and function’, ‘service provision’, and ‘awareness and information’. To explore practice guidelines available to speech pathologists to support their process of AT prescription a document analysis resulted in three categories identified across the documents published from five speech pathology associations. The analysis revealed the limited information provided to support speech pathologists decision making process around AT prescription and use with the TBI population.
In conclusion, our presentation provides an overview of the variety of AT used by speech pathologists to support communication and cognitive difficulties to support their RTW. We delve into some of the difficulties that are faced by speech pathologists to make evidence-based decisions in AT prescription for people with CCD post TBI.
Key messages
1. The AT utilised by speech pathologists to support RTW goals in people with CCD post TBI.
2. The factors which may influence decision making in AT prescription.
3. The need for more guidance on AT use and prescription within the TBI population.
**********
SPA staff
Student volunteer(s)
The information contained in this program is current at of the time of publishing but is subject to changes made without notice.
Disclaimer: © (2024) The Speech Pathology Association of Australia Limited. All rights reserved.
Important Notice, please read: The views expressed in this presentation and reproduced in these materials are not necessarily the views of, or endorsed by, The Speech Pathology Association of Australia Limited ("the Association"). The Association makes no warranty or representation in relation to the content, currency or accuracy of any of the materials comprised in this presentation. The Association expressly disclaims any and all liability (including liability for negligence) in respect of use of these materials and the information contained within them. The Association recommends you seek independent professional advice prior to making any decision involving matters outlined in this presentation including in any of the materials referred to or otherwise incorporated into this presentation.
.
